Boehringer Ingelheim Advances Weight Loss Drug Development

Boehringer Ingelheim has made significant progress in the development of its weight loss injections. The article also mentions other business news like Eli Lilly's acquisition and China blocking an AI deal.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

fazGerman1h ago

Business-Ticker: Boehringer macht wichtigen Schritt bei Abnehmspritzen

Christian Lindner wird Chef der Autoland AG +++ Pharmakonzern Eli Lilly übernimmt Entwickler von Blutkrebs-Therapien +++ China blockiert milliardenschweren KI-Deal von Meta +++ Neuigkeiten im Unternehmen-Liveblog.

Read full article →

PERSPECTA

PERSPECTA

Boehringer Ingelheim Advances Weight Loss Drug Development

Sources

Business-Ticker: Boehringer macht wichtigen Schritt bei Abnehmspritzen

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

Philippines Leads Region in Pension Coverage, Viability Questioned

Bosnia's Central Bank Reports Persistent High Inflation

Zenith Bank launches Cote d’ Ivoire subsidiary, strengthens Francophone West Africa presence

PERSPECTA